Return to Article Details
Venglustat, Lanreotide Acetate, and Tolvaptan as therapeutic options for the treatment of autosomic dominant polychistic kidney disease: a narrative review
Download
Download PDF
This is an outdated version published on April 12, 2021. Read the
most recent version
.